الفهرس 
Aim of the workOnly 14 pages are availabe for public view
 |  | from | 212 |  |  |
| | | from | 212 | | |
Abstract
Erythropoietin (EPO) is a glycoprotein hormone secreted mainly from the! ’,’
kidney and to a lesser extent from the liver. Serum EPO level was measured in 30 I
cirrhotic and 30 hepatocellular carcinoma (HCC) patients to assess its role in the I
pathogenesis of anemia of Ii vcr disease. It has been found that, serum EPO level I
increased significantly in both cirrhotic and HCC patients as compared 10 control. I
:
This increase was not related to iron deficiency or lowered hematocrit (HCT) value i
” and other factors may contribute. EPO has no role in the pathogenesis of anemia in I
our patients and so recombinant human EPO is not recommended as a \a:ullbk~
treatment for anemia in patients with liver disease.